| 1. |
- Kumagai, K., et al.
(författare)
-
Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer : A direct and adjusted indirect comparison meta-analysis
- 2015
-
Ingår i: European Journal of Surgical Oncology. - : Elsevier BV. - 0748-7983 .- 1532-2157. ; 41:3, s. 282-294
-
Forskningsöversikt (refereegranskat)abstract
- Several phase I/II studies of chemoradiotherapy for gastric cancer have reported promising results, but the significance of preoperative radiotherapy in addition to chemotherapy has not been proven. In this study, a systematic literature search was performed to capture survival and postoperative morbidity and mortality data in randomised clinical studies comparing preoperative (chemo)radiotherapy or chemotherapy versus surgery alone, or preoperative chemoradiotherapy versus chemotherapy for gastric and/or gastro-oesophageal junction (GOJ) cancer. Hazard ratios (HRs) for overall mortality were extracted from the original studies, individual patient data provided from the principal investigators of eligible studies or the earlier published meta-analysis. The incidences of postoperative morbidities and mortalities were also analysed. In total 18 studies were eligible and data were available from 14 of these. The meta-analysis on overall survival yielded HRs of 0.75 (95% CI 0.65-0.86, P < 0.001) for preoperative (chemo)radiotherapy and 0.83 (95% CI 0.67-1.01, P = 0.065) for preoperative chemotherapy when compared to surgery alone. Direct comparison between preoperative chemoradiotherapy and chemotherapy resulted in an HR of 0.71 (95% CI 0.45-1.12, P = 0.146). Combination of direct and adjusted indirect comparisons yielded an HR of 0.86 (95% CI 0.69-1.07, P = 0.171). No statistically significant differences were seen in the risk for postoperative morbidity or mortality between preoperative treatments and surgery alone, or preoperative (chemo)radiotherapy and chemotherapy. Preoperative (chemo)radiotherapy for gastric and GOJ cancer showed significant survival benefit over surgery alone. In comparisons between preoperative chemotherapy and (chemo)radiotherapy, there is a trend towards improved survival when adding radiotherapy, without increased postoperative morbidity or mortality.
|
|
| 2. |
- Michel, R., et al.
(författare)
-
Excitation functions for the production of radionuclides by neutron-induced reactions on C, O, Mg, Al, Si, Fe, Co, Ni, Cu, Ag, Te, Pb, and U up to 180 MeV
- 2015
-
Ingår i: Nuclear Instruments and Methods in Physics Research Section B. - : Elsevier BV. - 0168-583X .- 1872-9584. ; 343, s. 30-43
-
Tidskriftsartikel (refereegranskat)abstract
- Irradiation experiments with well-characterized, quasi mono-energetic neutrons of energies between 32.7 MeV and 175.4 MeV were performed at UCL/Louvain-la-Neuve and TSL/Uppsala. The abundances of relatively short-lived residual radionuclides from 13 different target elements were determined by 7-spectrometry. More than 100 excitation functions of neutron-induced reactions were unfolded based on the neutron spectra and the radionuclide abundances with the aid of additional information that was provided by "guess" excitation functions calculated by the TALYS 1.0 code. The results are compared with the sparse existing data from other authors. The new excitation functions were validated by calculation of and comparison with experimental thick-target production rates. Consistency with neutron excitation functions up to 1.6 GeV, which were derived earlier by unfolding the thick-target production rates, was so demonstrated.
|
|
